1. Home
  2. VSNT vs RGEN Comparison

VSNT vs RGEN Comparison

Compare VSNT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VSNT

Versant Media Group Inc. Class A Common Stock

N/A

Current Price

$40.05

Market Cap

6.0B

Sector

Industrials

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$131.71

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSNT
RGEN
Founded
2025
1981
Country
United States
United States
Employees
4400
N/A
Industry
Broadcasting
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.6B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
VSNT
RGEN
Price
$40.05
$131.71
Analyst Decision
Buy
Buy
Analyst Count
3
12
Target Price
$43.67
$167.67
AVG Volume (30 Days)
1.7M
1.1M
Earning Date
05-14-2026
05-05-2026
Dividend Yield
3.79%
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.15
Revenue
N/A
$141,236,000.00
Revenue This Year
N/A
$14.30
Revenue Next Year
N/A
$14.52
P/E Ratio
$3.83
$888.87
Revenue Growth
N/A
35.10
52 Week Low
$27.17
$100.99
52 Week High
$45.58
$175.77

Technical Indicators

Market Signals
Indicator
VSNT
RGEN
Relative Strength Index (RSI) 44.12 63.10
Support Level $38.91 $130.40
Resistance Level $43.02 $172.45
Average True Range (ATR) 1.22 5.86
MACD -0.35 1.69
Stochastic Oscillator 18.18 83.03

Price Performance

Historical Comparison
VSNT
RGEN

About VSNT Versant Media Group Inc. Class A Common Stock

Versant Media Group Inc is an independent media company comprised of NBCUniversal's cable television networks, including USA Network, CNBC, MSNBC, Oxygen, SYFY, and Golf Channel, along with complementary digital assets Fandango, Rotten Tomatoes, GolfNow, GolfPass, and SportsEngine.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: